TIPARP and neoplasm: Using the mouse subcutaneous EMT-6 tumor model, we observed that the armed OVs rM1-mGSDME_FL and rM1-mGSDME_NT exhibit superior antitumor efficacy compared to the parental M1 virus and control groups.